Healthy adult
Conditions
Interventions
Intake I period (test food) - washout period - Intake II period (placebo)
Intake I period (placebo) - washout period - Intake II period (test food)
Sponsors
TTC Co., Ltd
FURUKAWA Research &
Consulting
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Males and females from 20 to 69 years of age (2) Subjects who complained of nasal and ocular symptoms and judged. (3) Subjects who are judged as suitable for the study by the investigator. (4) Subjects who obtained the consent about participation in the study. (5) Subjects who do not take antiallergic drug account for more than half of whole.
Exclusion criteria
Exclusion criteria: (1) Subjects who constantly use health food richly containing involvement ingredient (2) Subjects who routinely take medicine affecting the test result. (3) Subjects who have severe nasal and eye symptoms affecting judgement of symptoms (4) Subjects who have a medical treatment (specific desensitization therapy) which may influence the outcome of the study. (5) Subjects who are engaged in drive a car or operate a hazardous machine. (6) Subjects judged as unsuitable for the study by the investigator for laboratory evidence or cardiopulmonary function. (7) Subjects who have a disease requiring regular medication or a history of serious disease for which medication was required. (8) Subjects who are liable to cause an allergy related to the study. (9) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination. (10) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. (11) Subjects who have participated in other clinical studies at the time of this study start (12) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. (13) Subjects who are judged as unsuitable for the study by the investigator for other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Record during pollen exposure (the number of sneezes and nose blowing, visual analog scale of nasal blockage, nasal itching, eye itching, watery eyes, throat symptoms, sleepiness and daily life) | — |
Secondary
| Measure | Time frame |
|---|---|
| Record after exposure pollen (the number of sneezes and nose blowing, visual analog scale of nasal blockage, nasal itching, eye itching, watery eyes , throat symptoms, sleepiness, and daily life) visual analog scale of awaking. eosinophil of nasal mucus. Doctor observation of the nasal mucus and the nose | — |
Countries
Japan
Contacts
Public ContactChiharu Goto
TTC Co., Ltd. Clinical Research Planning Department
Outcome results
None listed